Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| RN Radical NumericsCompany profile Builds multimodal AI models that read, write, and design across DNA, RNA, and proteins Builds multimodal AI models that read, write, and design across DNA, RNA, and proteins | $50M | Seed | Biotech | United States | Investors | |
| NM |
Ranked by rounds participated in · All time
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
Develops antibiotic-free wound dressing that prevents infection and promotes healing in chronic wounds
Develops antibiotic-free wound dressing that prevents infection and promotes healing in chronic wounds
| €1.6M |
| Seed |
| Biotech, Healthtech |
| Estonia |
| Investors |
| S Develops ultrasound-mediated nonviral genetic medicines | $125M | Series B | Biotech | United States | Investors |
| F FesariusTherapeuticsCompany profile Develops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgery Develops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgery | $20M | Series A | Biotech, Healthtech | United States | Investors |
| A AntogenCompany profile Develops proteomics-based immune surveillance diagnostics and research tools for clinical and research markets Develops proteomics-based immune surveillance diagnostics and research tools for clinical and research markets | Undisclosed | Seed | Biotech | United States | Investors |
| GM GT Medical TechnologiesCompany profile Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors | $100M | Series ESeries C+ | Biotech, Healthtech | United States | Investors |
| EB Element BiosciencesCompany profile Develops genomic and multiomic sequencing platforms for research, translational science, and diagnostics Develops genomic and multiomic sequencing platforms for research, translational science, and diagnostics | $175M | Series ESeries C+ | Biotech | United States | Investors |
| RB Rejuvenate BioCompany profile Develops gene therapies for age-related and chronic diseases in animals and humans Develops gene therapies for age-related and chronic diseases in animals and humans | $6M | StrategicUndisclosed | Biotech | United States | Investors |
| CT City TherapeuticsCompany profile Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas | $99.5M | Series B | Biotech | United States | Investors |
| OP Develops RNAi therapeutics for various diseases | ₩110B | StrategicUndisclosed | Biotech | South Korea | Investors |